Hargreave Hale Q&A with Chairman & Fund Manager Giles Hargreave
12 January 2017
Arbutus Biopharma Corporation (NASDAQ: ABUS), a clinical-stage biopharmaceutical company, presents a promising opportunity for investors seeking to delve into the dynamic biotechnology sector. With a market capitalization of $794.3 million,..
Altimmune, Inc. (NASDAQ: ALT) has captured the attention of investors with a staggering potential upside of 246.41%, according to recent analyst ratings. Specializing in the healthcare sector, specifically in biotechnology,..
Fulgent Genetics, Inc. (NASDAQ: FLGT), a prominent player in the Healthcare sector, specifically within the Diagnostics & Research industry, presents a compelling case for investors with a noted potential upside..
Owens & Minor, Inc. (NYSE: OMI), a prominent player in the medical distribution industry, offers a compelling investment opportunity with a potential upside of 94.29%. Operating within the healthcare sector,..
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is carving out its niche in the competitive biotechnology sector with a focus on innovative cell therapies for cancer treatment. Headquartered in San Carlos, California,..
COMPASS Pathways Plc (NASDAQ: CMPS), a pioneering entity in the healthcare sector, has carved out a niche in the burgeoning field of mental health treatment. Specializing in innovative therapies, the..
Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology company headquartered in San Diego, California, is making waves in the biotech sector with its promising therapeutic developments. With a current market..
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) is making waves in the biotechnology sector, offering investors a promising opportunity with a significant potential upside of 53.91%. As a commercial-stage biopharmaceutical company,..
Sana Biotechnology, Inc. (NASDAQ: SANA), an innovative player in the healthcare sector, is capturing investor attention with its significant potential upside of 89.44%. This Seattle-based biotechnology firm is making strides..
InnovAge Holding Corp. (NASDAQ: INNV) is making waves in the healthcare sector, specifically within the medical care facilities industry. As a provider of comprehensive services for seniors through its Program..
Theravance Biopharma, Inc. (NASDAQ: TBPH) stands out in the competitive landscape of the biotechnology sector with its significant market potential and promising pipeline. With a market capitalization of $971.9 million,..
Weave Communications, Inc. (NASDAQ: WEAV), a key player in the health information services industry, has been catching the eye of investors with its innovative customer experience and payments software platform..
MeiraGTx Holdings plc (NASDAQ: MGTX) stands at an intriguing juncture for investors, especially those with a keen interest in the biotechnology sector. With its current market capitalization at $623 million..
Cross Country Healthcare, Inc. (NASDAQ: CCRN), a prominent player in the healthcare staffing industry, has been navigating through a volatile market environment. With a market capitalization of $300.41 million, the..
Investors with an eye on the biopharmaceutical sector may want to consider Avadel Pharmaceuticals plc (NASDAQ: AVDL), a company that has been attracting attention due to its substantial revenue growth..
Orthofix Medical Inc. (NASDAQ: OFIX), a prominent player in the healthcare sector, particularly in the medical devices industry, presents an intriguing opportunity for investors seeking growth in a specialized market...
Investors seeking opportunities in the healthcare information services industry should keep an eye on Definitive Healthcare Corp. (NASDAQ: DH), a company that offers a SaaS-based healthcare commercial intelligence platform. Despite..
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company specializing in aesthetic products, presents a unique investment opportunity with a potential upside of 264.81%, according to the latest analyst ratings. This..
Enhabit, Inc. (NASDAQ: EHAB), a key player in the U.S. healthcare sector, offers a comprehensive suite of home health and hospice services. With a market capitalization of $534.28 million, Enhabit..
Geron Corporation (NASDAQ: GERN), a commercial-stage biopharmaceutical company, is capturing the attention of investors with its promising potential upside of 162.77%. This California-based company, specializing in oncology therapeutics, might be..
